Anlon Healthcare Completes Acquisition of 63.98% Equity Stake in Remember India Health Links Private Limited

Anlon Healthcare Limited has successfully completed the acquisition of a 63.98% (Sixty Three Point Nine Eight percent) equity shareholding in Remember India Health Links Private Limited on May 8, 2026. This milestone follows the execution of a Share Purchase Agreement (SPA) dated April 16, 2026, and was disclosed to the stock exchanges pursuant to Regulation 30(7) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Acquisition Details

The completion of this acquisition marks a significant corporate development for Anlon Healthcare. Consequent to the transaction, Remember India Health Links Private Limited has become a subsidiary of Anlon Healthcare Limited. The key details of the acquisition are summarised below:

Parameter: Details Acquirer: Anlon Healthcare Limited Target Company: Remember India Health Links Private Limited Stake Acquired: 63.98% equity shareholding Date of Completion: May 8, 2026 SPA Execution Date: April 16, 2026 Post-Acquisition Status: Target Company becomes a subsidiary

Regulatory Compliance

The acquisition has been carried out in compliance with Section 179(3)(e) and (j) and all other applicable provisions of the Companies Act, 2013. The disclosure was made under Regulation 30(7) read with Para A of Part A of Schedule III of the SEBI Listing Regulations, and in continuation of the earlier intimation dated April 16, 2026. Additional details, as required under the SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, were provided in the earlier disclosure dated April 16, 2026.

The disclosure was signed by Punitkumar Rasadia, Managing Director of Anlon Healthcare Limited (DIN: 06696258), on May 8, 2026.

Anlon Healthcare Limited has filed its annual disclosure under Regulation 30(1), 30(2), and Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, for the financial year 2025-2026. The disclosure, dated April 01, 2026, was submitted to the listing departments of both BSE Limited and the National Stock Exchange of India Ltd. It was signed by Punitkumar Rasadia, Managing Director (DIN: 06696258), on behalf of all promoters of the company.

Key Declaration by Promoters

In the disclosure, the promoters and members of the promoter group formally declared that no encumbrance — direct or indirect — was created on shares of Anlon Healthcare Limited at any point during the financial year 2025-2026. This declaration is in compliance with the requirements set out under Regulation 31(4) of the SEBI Takeover Regulations, 2011, as amended.

Promoter and Promoter Group Members

The disclosure includes an Annexure listing all individuals and entities belonging to the promoter and promoter group of the company. The following table presents the complete list as submitted:

Sr. No.: Name Category 1 MEET ATULKUMAR VACHHANI Promoter 2 PUNITKUMAR R RASADIA Promoter 3 MAMATA PUNITKUMAR RASADIA Promoter 4 RASADIA BHANUMATI RAMESHBHAI Promoter Group 5 SHILPABEN MEETBHAI VACHHANI Promoter Group 6 RASADIA KHUSH PUNITKUMAR Promoter Group 7 RAMESHBHAI MAGANBHAI RAMOTIYA Promoter Group 8 RAMOTIYA RAMABEN Promoter Group 9 JAYESH RAMESHBHAI RAMOTIYA Promoter Group 10 SANJAY RAMOTIYA R Promoter Group 11 ATULBHAI SHYAMLAL VACHHANI Promoter Group 12 VACHHANI BHARTIBEN ATULBHAI Promoter Group 13 NEHA NIRMAL PATEL Promoter Group 14 GYANA MEETBHAI VACHHANI Promoter Group 15 VARI MEETBHAI VACHHANI Promoter Group 16 ANLON CHEMICAL RESEARCH ORGANIZATION Promoter Group 17 ANLON LIFESCIENCE PRIVATE LIMITED Promoter Group 18 ADVINTEL MEDICARE PRIVATE LIMITED Promoter Group 19 RAMOTIYA MAGANBHAI RAMESHBHAI HUF Promoter Group

Filing Details

The disclosure was submitted to the stock exchanges in accordance with regulatory requirements. Key details of the filing are summarised below:

Parameter: Details Company Name: ANLON HEALTHCARE LIMITED CIN: U24230GJ2013PLC077543 Filing Date: April 01, 2026 Financial Year: 2025-2026 Regulation: Regulation 31(4), SEBI Takeover Regulations, 2011 Signed By: Punitkumar Rasadia, Managing Director (DIN: 06696258) Registered Office: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot-360005, Gujarat, India

The filing confirms that all promoters and promoter group members of Anlon Healthcare Limited are in compliance with the annual disclosure requirements prescribed by SEBI under the Takeover Regulations for the financial year 2025-2026.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.